Compare UPC & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UPC | ORIS |
|---|---|---|
| Founded | 1998 | 2014 |
| Country | China | China |
| Employees | N/A | 69 |
| Industry | Biotechnology: Pharmaceutical Preparations | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5M | 1.3M |
| IPO Year | 2020 | N/A |
| Metric | UPC | ORIS |
|---|---|---|
| Price | $2.28 | $0.76 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 3.6K | ★ 1.3M |
| Earning Date | 04-29-2025 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $152.96 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.00 | $0.06 |
| 52 Week High | $11.00 | $1.87 |
| Indicator | UPC | ORIS |
|---|---|---|
| Relative Strength Index (RSI) | 31.60 | 45.90 |
| Support Level | $2.00 | $0.11 |
| Resistance Level | $2.91 | $1.01 |
| Average True Range (ATR) | 0.21 | 0.20 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 30.70 | 60.72 |
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).